System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Joost Felius is an expert in Ophthalmology at Baylor Scott & White Health (United States). Joost Felius has authored 268 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 569 (community average: 125). How the SLR is computed.

LeadR Profile

Joost Felius Baylor Scott & White Health United States
569 ScienceLeadR Reputation 569

Unlock

Register Login
Network Map

Ophthalmology

Subspecialties: Transplantation - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1992 - 2026
Source: PubMed

Baylor Scott & White Research Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 268

Citations

Citations: 6 708 1st author: 31 Last author: 25 Unique author: 0

Main journals

J AAPOS 46
J Heart Lung Transplant 45
Invest Ophthalmol Vis Sci 44
J Card Fail 14
Arch Ophthalmol 12

Best Journals

Circulation 2
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: results from the Trifecta-Heart study.
PMID 41833593 — cells, genes, heart, biopsy, heart transplantation, transplants, lung transplantation, plasma		J Heart Lung Transplant20260
Bicarbonate Purge in Impella: Safety and Feasibility.
PMID 41709353 — artificial organs, mortality, safety, hemorrhage, stroke, heparin, contraindications, solutions		ASAIO J20260
Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study.
PMID 41241034 — heart, biopsy, histology, heart transplantation, transplants, therapeutics		J Heart Lung Transplant20254
Regional differences in primary graft dysfunction: A report from the international consortium on PGD.
PMID 40057054 — mortality, incidence, primary graft dysfunction, prostaglandins d, risk factors, heart transplantation, transplants, lung transplantation		J Heart Lung Transplant202512
Exercise capacity and cardiac allograft ischemic time in recent heart transplant recipients.
PMID 40143894 — exercise, tissue and organ procurement, exercise test, cold ischemia, heart, heart transplantation, transplants, allografts		JHLT Open20242

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 6
N/A 5

By status:

Completed 7
Recruiting 2
Terminated 2

By type:

Interventional 8
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 3
multicentric5to9 0
multicentricup10 4

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Trifecta Heart cfDNA MMDx Study
NCT04707872 — graft rejection, cells, research design, genes, blood, antibodies, heart, biopsy, cell-free nucleic acids, transplants, gene expression		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS